Johnson & Johnson EVP Thomas Cavanaugh files initial beneficial ownership statement
JNJ•Form 3 filing details
- Johnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, including 428 held in a 401(k).
- Filing also reports employee stock options covering 122,556 shares, exercise prices from $151.41 to $243.45.
- Restricted share units total 5,337 shares.
